UNSPSC 51291706: Flerobuterol

This classification denotes a beta-adrenergic agonist and antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F05RR5M463. European Medicines Agency schedules Flerobuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07638MIG. Flerobuterol generally arises in the molecular formula C12H18FNO.

UNSPSC 51291706 Flerobuterol is a Commodity code representing pharmaceutical products, though the recent state and local activity under this code shows a material mismatch: the single identified solicitation tags naloxone and drug deactivation systems, which fall outside the flerobuterol scope. Naloxone is an opioid antagonist and drug-deactivation systems are waste-management products, not bronchodilator pharmaceuticals. The code appears to reflect a misclassification in the issuing body's tagging rather than representative activity for flerobuterol procurement itself.

Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement, potentially FEMA-funded, carried a response deadline of July 26, 2023, at 2:00 pm and required vendors to submit electronic bids through the county's e-Procurement Portal with all shipping and delivery costs included. Beyond this single opportunity, the source does not surface additional recent state and local solicitations under the flerobuterol code, suggesting minimal current procurement activity for actual flerobuterol products or a pattern of miscoding by issuing bodies. Business development professionals evaluating this code should verify tagging accuracy before committing resources to pursue opportunities posted under it.